David J. Chase

After a 35-year career in academia and industry, David Chase retired as Director of Scientific and Medical Affairs in Johnson & Johnson’s Consumer Companies. He served in this role for the Women’s Health franchises for the entire 15 years he was at J & J, as well as for Baby and Skin Care for several years. David’s group had or shared responsibility for safety assessments and testing of ingredients, materials, experimental prototypes, and final products; clinical studies to demonstrate efficacy/performance and safety of products; contributing biological perspective to product discovery and development; establishing and maintaining relationships with extramural biomedical professionals; interacting with FDA on matters relating to medical device development and marketing clearance; and educating R&D, senior business executives, and other business partners in relevant areas of biology and medicine. David had worldwide responsibilities, including clinical studies in the U.K., Germany, Poland, the Philippines, and China, as well as the U.S.

David earned a B.A. at the University of Montana and a Ph.D. at the University of California, Berkeley, focusing on physiology, endocrinology, and reproductive biology. He did postdoctoral research in biochemical endocrinology at the University of Michigan for six years, and taught and did research at the State University of New York, Binghamton, for six years before starting his career in the healthcare industry. Before joining Johnson & Johnson in 1999, David was responsible for Phase 2-3 clinical studies of women’s health drugs (prevention of postmenopausal osteoporosis, Organon) and for finding and reviewing drug candidates for in-licensing (various indications related to women’s health, Wyeth).